HomeCRNX • NASDAQ
add
Crinetics Pharmaceuticals Inc
Previous close
$29.99
Day range
$29.59 - $30.85
Year range
$24.10 - $62.53
Market cap
2.81B USD
Avg Volume
685.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 361.00K | -43.59% |
Operating expense | 35.53M | 70.57% |
Net income | -96.77M | -44.59% |
Net profit margin | -26.81K | -156.34% |
Earnings per share | -1.04 | -11.83% |
EBITDA | -110.48M | -51.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.27B | 41.42% |
Total assets | 1.36B | 39.17% |
Total liabilities | 107.33M | 3.98% |
Total equity | 1.25B | — |
Shares outstanding | 93.68M | — |
Price to book | 2.24 | — |
Return on assets | -19.92% | — |
Return on capital | -20.77% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -96.77M | -44.59% |
Cash from operations | -88.45M | -67.35% |
Cash from investing | -85.96M | -27,919.09% |
Cash from financing | 4.44M | -98.87% |
Net change in cash | -169.98M | -149.84% |
Free cash flow | -47.18M | -69.57% |
About
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018. Wikipedia
Founded
Nov 18, 2008
Website
Employees
437
